References
- Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, et al. Diagnostic impact of [18F]flutemetamol PET in early-onset dementia. Alzheimers Res Ther 2017;9:2. https://doi.org/10.1186/s13195-016-0228-4
- Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement 2013;9:e-1-e-16.
- Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis 2010;19:1401-1408. https://doi.org/10.3233/JAD-2010-1337
Cited by
- A Study on the Optimal Image Acquisition Time of 18F- Flutemetamol using List Mode vol.15, pp.6, 2018, https://doi.org/10.7742/jksr.2021.15.6.891